drugset
drugset / Trial / NCT01395069

Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract Surgery

NCT01395069 ↗

Phase 4 Completed 162 enrolled Queen's University
RandomizedParallel-groupTriple-blindPrevention

Summary

Assess prophylactic efficacy of topical non-steroidal anti-inflammatory drops in preventing macular edema. Patient undergoing uncomplicated cataract surgery will be enrolled and randomized to nepafenac, ketorolac, or placebo. Follow-up will occur at 1 month with ocular coherence tomography (OCT).

Timeline

Start
2010-02
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketorolac Other / unclassified 0.5 % Topical
Comparator Nepafenac Other / unclassified 0.1 % Topical

Indications

macular retinal edema